Theravance Biopharma, Inc.

NASDAQ:TBPH

9.86 (USD) • At close December 26, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q3
Revenue 16.86814.25614.50317.56515.69313.74910.41714.64912.45111.0513.19614.94513.19412.91414.25718.7318.25715.00819.86229.49912.42726.155.33815.73712.83823.4768.3194.5154.2753.5093.0875.69219.0755.47118.413.89310.6987.13420.4011.4336.3362.9740.9450.1750.0240.0050.0224.4760
Cost of Revenue 09.9541.5334.3331.3391.3381.6561.2481.6252.2341.48231.22643.73951.09367.59965.16567.37162.40466.01367.02552.00646.39953.8180.6320.70547.1730.8263.1160.9851.3640.5651.1460.3320.6380.7783.2010.5810.5050.3713.2220.3690.2790.18832.4732.30130.425.408100.8030
Gross Profit 16.8684.30212.9713.23214.35412.4118.76113.40110.8268.81611.714-16.281-30.545-38.179-53.342-46.435-49.114-47.396-46.151-37.526-39.579-20.249-48.4815.10512.133-23.6977.4931.3993.292.1452.5224.54618.7434.83317.6320.69210.1176.62920.03-1.7895.9672.6950.757-32.295-32.277-30.395-25.386-96.3270
Gross Profit Ratio 10.3020.8940.7530.9150.9030.8410.9150.8690.7980.888-1.089-2.315-2.956-3.741-2.479-2.69-3.158-2.324-1.272-3.185-0.774-9.0820.960.945-1.0090.9010.310.770.6110.8170.7990.9830.8830.9580.1780.9460.9290.982-1.2480.9420.9060.801-184.543-1,344.875-6,079-1,153.909-21.5210
Reseach & Development Expenses 9.2689.9548.5368.3148.3119.42514.57215.3479.86715.57123.25331.22543.73951.09367.59965.16567.37162.40466.01367.02552.00646.39953.81852.26952.69348.62147.76551.05139.34342.92740.56542.01331.95132.06935.67832.40230.36730.37736.01942.19238.32446.28341.72332.4732.30130.425.40828.13626.089
General & Administrative Expenses 00010.3920008.73400000000000000000000000000000000000000019.2626.506
Selling & Marketing Expenses 0005.10008000000000000000000000000000000000000000-12.7990
SG&A 16.87517.05615.64115.49216.14219.27819.18316.73416.27716.98623.63821.51621.29925.93130.5530.05527.50124.7826.32533.04625.62222.22725.18625.45721.8925.00724.70429.52420.94424.33920.78620.36620.28620.26123.59624.06422.84521.54521.74821.77217.70513.11819.05211.7858.8018.5576.7886.4636.506
Other Expenses 1.5620000000000000000.126-1.7360000000000.20200000000000000.2140000000
Operating Expenses 26.14327.0124.17723.80624.45328.70333.75532.08126.14432.55746.89152.74165.03877.02498.14995.2294.87287.18492.338100.07177.62868.62679.00477.72674.58373.62872.46980.57560.28767.26661.35162.37952.23752.3359.27456.46653.21251.92257.76763.96456.02959.40160.77544.25541.10238.95732.19667.14532.595
Operating Income -10.837-12.754-11.207-6.241-8.76-16.123-24.912-17.432-14.2026.859-38.502-56.167-53.615-64.11-83.892-76.49-76.615-72.176-72.476-70.572-65.201-42.476-73.666-62.621-62.45-48.704-64.976-79.176-56.997-65.121-58.829-57.834-33.494-47.497-41.642-55.774-43.095-45.293-37.737-65.753-50.062-56.706-60.018-44.08-41.078-38.952-32.174-29.182-32.595
Operating Income Ratio -0.642-0.895-0.773-0.355-0.558-1.173-2.391-1.19-1.1410.621-2.918-3.758-4.064-4.964-5.884-4.084-4.196-4.809-3.649-2.392-5.247-1.624-13.8-3.979-4.864-2.075-7.811-17.536-13.333-18.558-19.057-10.161-1.756-8.682-2.262-14.327-4.028-6.349-1.85-45.885-7.901-19.067-63.511-251.886-1,711.583-7,790.4-1,462.455-6.520
Total Other Income Expenses Net 0.785-2.4670.8051.2241.1771.9362.429-1.885-1.82114.9052.47723.98218.311.4854.449.2573.0659.328-10.435.0151.2182.8391.1669.1792.3581.0960.033-0.757-9.012-0.712-1.107-0.9310.3440.3080.1860.1130.1040.2040.2110.9830.6680.2140000000
Income Before Tax -10.052-15.221-10.402-5.017-7.583-14.187-22.483-14.261-16.023-8.196-25.422-32.186-35.315-52.625-79.452-67.233-73.55-62.848-82.906-65.557-63.983-39.637-72.5-53.442-60.092-47.608-64.943-79.934-66.009-65.833-59.936-58.764-33.15-47.189-41.456-55.661-42.991-45.089-37.526-64.77-49.394-56.492-60.018-44.08-41.078-38.952-32.174-29.182-32.595
Income Before Tax Ratio -0.596-1.068-0.717-0.286-0.483-1.032-2.158-0.974-1.287-0.742-1.926-2.154-2.677-4.075-5.573-3.59-4.029-4.188-4.174-2.222-5.149-1.516-13.582-3.396-4.681-2.028-7.807-17.704-15.441-18.761-19.416-10.324-1.738-8.625-2.252-14.298-4.019-6.32-1.839-45.199-7.796-18.995-63.511-251.886-1,711.583-7,790.4-1,462.455-6.520
Income Tax Expense 2.6461.3081.2623.4941.3671.458-0.395-0.003-932.654-0.0050.524-0.151-0.007-0.220.227-8.7990.0930.0390.1470.049-5.5520.2010.08-3.256-0.659-6.790.1446.9880.8680.4545.3838.5680.8120.0360.694-10.8354.3232.5144.948-0.465.1011.7230000000
Net Income -12.698-16.529-11.664-8.511-8.95-15.645-22.088-14.258916.631-8.191-25.946-32.035-35.308-52.405-79.679-58.434-73.643-62.887-83.053-65.606-58.431-39.838-72.58-50.186-59.433-40.818-65.087-86.922-66.877-66.287-65.319-67.332-33.962-47.225-42.15-44.826-47.314-47.603-42.474-64.31-54.495-58.215-60.018-44.08-41.078-38.952-32.174-29.182-32.595
Net Income Ratio -0.753-1.159-0.804-0.485-0.57-1.138-2.12-0.97373.619-0.741-1.966-2.144-2.676-4.058-5.589-3.12-4.034-4.19-4.182-2.224-4.702-1.523-13.597-3.189-4.629-1.739-7.824-19.252-15.644-18.891-21.159-11.829-1.78-8.632-2.29-11.515-4.423-6.673-2.082-44.878-8.601-19.575-63.511-251.886-1,711.583-7,790.4-1,462.455-6.520
EPS -0.26-0.34-0.24-0.17-0.17-0.28-0.35-0.2112.14-0.11-0.34-0.44-0.48-0.8-1.24-0.92-1.16-1-1.4-1.17-1.05-0.72-1.32-0.92-1.1-0.76-1.22-1.64-1.27-1.27-1.27-1.36-0.73-1.06-1.1-1.23-1.4-1.42-1.29-2.02-1.72-1.83-1.89-1.39-1.29-1.23-1-0.919-1.027
EPS Diluted -0.26-0.34-0.24-0.17-0.17-0.28-0.35-0.2112.14-0.11-0.34-0.43-0.48-0.8-1.24-0.92-1.16-1-1.4-1.17-1.05-0.72-1.32-0.92-1.1-0.76-1.22-1.64-1.27-1.27-1.27-1.36-0.73-1.06-1.1-1.17-1.4-1.42-1.29-2.02-1.72-1.83-1.86-1.37-1.27-1.21-1-0.905-1.01
EBITDA -8.66-13.598-8.24-2.675-5.635-12.281-20.277-12.462-12.853-19.16-38.502-19.496-53.615-38.617-65.297-54.422-59.824-48.884-70.62-55.562-53.093-29.155-62.34-48.513-57.337-44.681-61.906-76.779-62.923-62.72-56.716-57.403-32.359-47.043-40.943-55.077-42.375-44.698-37.151-64.972-48.987-56.02-59.286-43.386-40.521-38.253-31.471-28.44-31.817
EBITDA Ratio -0.513-0.954-0.667-0.19-0.444-0.906-1.954-0.936-0.8780.82-0.538-0.144-1.64-3.176-4.724-2.966-3.395-3.429-2.895-1.95-4.499-1.214-12.11-3.137-4.514-1.937-7.442-17.231-13.07-18.152-18.373-10.161-1.756-8.599-2.224-14.148-3.924-6.265-1.821-45.885-7.901-19.067-62.737-247.92-1,688.375-7,650.6-1,430.5-6.3540